News & Press


In Memory of Christopher Charles Duffield

April 16, 2021

Guest blog from Chris Duffield’s best friend Mark and his support dog Ben: Christopher, known as Chris, was a friend, son and brother of the best kind. He always had a hand out to support a friend or family member and a kind word to say to all. He live …



Melanoma Research Foundation Announces Doug Brodman as Board Chair

March 30, 2021

WASHINGTON, DC, March 30 – The Melanoma Research Foundation (MRF), the largest independent organization devoted to melanoma will celebrate its 25th Anniversary in 2021. Today it announced the appointment of Douglas (Doug) Brodman as Chairman of the Boa …



MRF 25th Anniversary: Managing Immunotherapy-Related Treatment Side Effects

March 24, 2021

For our 25th anniversary, we share a guest blog from Douglas B. Johnson, MD, MSCI, from Vanderbilt Medical Center and recipient of a research grant provided by the MRF/MRF Breakthrough Consortium:  “Patient with metastatic melanoma” – these words carri …



Leading Skin Cancer Organizations Urge the FDA to Ban Tanning Beds for Minors

March 12, 2021

WASHINGTON, DC – The Melanoma Research Foundation (MRF) recently signed- on to a letter from the National Council of Skin Cancer Prevention (NCSCP) urging the U.S. Food and Drug Administration (FDA) to finalize the proposed rules entitled General and P …



FDA Grants Alkermes Orphan Drug Designation for the Treatment of Mucosal Melanoma

March 11, 2021

WASHINGTON, DC – The U.S. Food and Drug Administration (FDA) has recently granted orphan drug designation for the treatment of mucosal melanoma to Alkermes’ investigational engineered interleukin-2 (IL-2) variant immunotherapy, nemvaleukin alfa (“nemva …